Status:
COMPLETED
New Mammographic Techniques Versus MRI in Assessment of Breast Lesions
Lead Sponsor:
Cairo University
Conditions:
Breast Diseases
Eligibility:
FEMALE
Brief Summary
Value of New Mammography Techniques in Comparison to Dynamic Contrast-Enhanced MRI of the Breast in the Detection and Diagnosis of Breast lesions
Detailed Description
Combined use of contrast-enhanced digital mammography (CEDM), and digital breast tomosynthesis (DBT), may be a reasonable alternative to MRI.
Eligibility Criteria
Inclusion
- Inclusion criteria
- Breast Imaging Reporting and Data System (BI-RADS) 3, 4, and 5 breast lesions.
- Clinical indication for MRI breast imaging.
- No histologically proven cancer before enrollment. Exclusion criteria
- 1\. Pregnancy or possible pregnancy. 2. History of allergy to an iodinated contrast agent. 3. Renal impairment. 4. Contraindication for MRI examination
Exclusion
Key Trial Info
Start Date :
June 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06089148
Start Date
June 1 2015
End Date
December 1 2016
Last Update
October 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.